Refractory Lung Carcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB14825Danvatirsen2Active Not Recruiting1
DB11714Durvalumab2Active Not Recruiting1